Examination of Regional Lymph Nodes by Sentinel Node Biopsy and Molecular Analysis Provides New Staging Facilities in Primary Cutaneous Melanoma
Hans-Juergen Blaheta(University of Tübingen), Burkhard Bueltmann(University of Tübingen), Marcel H. Thelen(University of Tübingen), Karl Sotlar(University of Tübingen), Claus Garbe(University Children's Hospital Tübingen), Birgit Schittek(Hertie Institute for Clinical Brain Research), Ulf Ellwanger, Helmut Breuninger, Evelyn Maczey, G. Rassner
Cited by 183
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Diagnostic criteria and classification of mastocytosis: a consensus proposal
|Leukemia Research|2001|1.1k
Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study
|The Lancet Oncology|2014|978
Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines
|European Journal of Cancer|2019|589
Systematic Review of Medical Treatment in Melanoma: Current Status and Future Prospects
|The Oncologist|2011|579